Effects of ischemic pre- and postconditioning on HIF-1α, VEGF and TGF-β expression after warm ischemia and reperfusion in the rat liver

Comparative Hepatology

Volumn 10, Issue , 2011, Pages

  Knudsen, Anders R ^a   Kannerup, Anne Sofie ^a   Grønbæk, Henning ^a   Andersen, Kasper J ^a   Funch Jensen, Peter ^a   Frystyk, Jan ^a   Flyvbjerg, Allan ^a   Mortensen, Frank V ^a  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

HYPOXIA INDUCIBLE FACTOR 1ALPHA; TRANSFORMING GROWTH FACTOR BETA; VASCULOTROPIN A;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; GENE EXPRESSION; ISCHEMIC POSTCONDITIONING; ISCHEMIC PRECONDITIONING; LIVER ISCHEMIA; LIVER PERFUSION; LIVER PROTECTION; MALE; NONHUMAN; PROTEIN EXPRESSION; RAT; REPERFUSION INJURY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

EID: 79960560537     PISSN: None     EISSN: 14765926     Source Type: Journal    
DOI: 10.1186/1476-5926-10-3     Document Type: Article

References (34)

1. Fong Y, Fortner J, Sun RL, Brennan MF, Blumgart LH. Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: analysis of 1001 consecutive cases. AnnSurg 1999, 230:309-318.
2. Abdalla EK, Vauthey JN, Ellis LM, Ellis V, Pollock R, Broglio KR, Hess K, Curley SA. Recurrence and outcomes following hepatic resection, radiofrequency ablation, and combined resection/ablation for colorectal liver metastases. AnnSurg 2004, 239:818-825.
3. Pawlik TM, Scoggins CR, Zorzi D, Abdalla EK, Andres A, Eng C, Curley SA, Loyer EM, Muratore A, Mentha G, et al. Effect of surgical margin status on survival and site of recurrence after hepatic resection for colorectal metastases. AnnSurg 2005, 241:715-722. discussion.
4. Kooby DA, Stockman J, Ben-Porat L, Gonen M, Jarnagin WR, DeMatteo RP, Tuorto S, Wuest D, Blumgart LH, Fong Y. Influence of transfusions on perioperative and long-term outcome in patients following hepatic resection for colorectal metastases. AnnSurg 2003, 237:860-869.
5. Jarnagin WR, Gonen M, Fong Y, DeMatteo RP, Ben-Porat L, Little S, Corvera C, Weber S, Blumgart LH. Improvement in perioperative outcome after hepatic resection: analysis of 1,803 consecutive cases over the past decade. AnnSurg 2002, 236:397-406.
6. Rosen CB, Nagorney DM, Taswell HF, Helgeson SL, Ilstrup DM, van Heerden JA, Adson MA. Perioperative blood transfusion and determinants of survival after liver resection for metastatic colorectal carcinoma. AnnSurg 1992, 216:493-504.
7. van der Bilt JD, Livestro DP, Borren A, van HR, Borel RI. European survey on the application of vascular clamping in liver surgery. Dig Surg 2007, 24:423-435. 10.1159/000108325, 17855781.
8. Delva E, Camus Y, Nordlinger B, Hannoun L, Parc R, Deriaz H, Lienhart A, Huguet C. Vascular occlusions for liver resections. Operative management and tolerance to hepatic ischemia: 142 cases. Ann Surg 1989, 209:211-218.
9. Hannoun L, Borie D, Delva E, Jones D, Vaillant JC, Nordlinger B, Parc R. Liver resection with normothermic ischaemia exceeding 1 h. Br J Surg 1993, 80:1161-1165. 10.1002/bjs.1800800933, 8402122.
10. Belghiti J, Noun R, Malafosse R, Jagot P, Sauvanet A, Pierangeli F, Marty J, Farges O. Continuous versus intermittent portal triad clamping for liver resection: a controlled study. AnnSurg 1999, 229:369-375.
11. Jaeschke H. Molecular mechanisms of hepatic ischemia-reperfusion injury and preconditioning. Am J Physiol Gastrointest Liver Physiol 2003, 284:G15-G26.
12. Koti RS, Seifalian AM, Davidson BR. Protection of the liver by ischemic preconditioning: a review of mechanisms and clinical applications. Dig Surg 2003, 20:383-396. 10.1159/000072064, 12840597.
13. Clavien PA, Selzner M, Rudiger HA, Graf R, Kadry Z, Rousson V, Jochum W. A prospective randomized study in 100 consecutive patients undergoing major liver resection with versus without ischemic preconditioning. Ann Surg 2003, 238:843-850. 10.1097/01.sla.0000098620.27623.7d, 1356166, 14631221.
14. Lee WY, Lee SM. Ischemic preconditioning protects post-ischemic oxidative damage to mitochondria in rat liver. Shock 2005, 24:370-375. 10.1097/01.shk.0000175895.33415.cd, 16205323.
15. Sun K, Liu ZS, Sun Q. Role of mitochondria in cell apoptosis during hepatic ischemia-reperfusion injury and protective effect of ischemic postconditioning. World J Gastroenterol 2004, 10:1934-1938.
16. Wu BQ, Chu WW, Zhang LY, Wang P, Ma QY, Wang DH. Protection of preconditioning, postconditioning and combined therapy against hepatic ischemia/reperfusion injury. Chin J Traumatol 2007, 10:223-227.
17. Schofield CJ, Ratcliffe PJ. Oxygen sensing by HIF hydroxylases. NatRevMolCell Biol 2004, 5:343-354.
18. Lario S, Mendes D, Bescos M, Inigo P, Campos B, Alvarez R, Alcaraz A, Rivera-Fillat F, Campistol JM. Expression of transforming growth factor-beta1 and hypoxia-inducible factor-1alpha in an experimental model of kidney transplantation. Transplantation 2003, 75:1647-1654. 10.1097/01.TP.0000063128.86981.B2, 12777850.
19. Semenza G. Signal transduction to hypoxia-inducible factor 1. BiochemPharmacol 2002, 64:993-998.
20. Michalopoulos GK. Liver regeneration. JCell Physiol 2007, 213:286-300.
21. van der Bilt JD, Kranenburg O, Nijkamp MW, Smakman N, Veenendaal LM, Te Velde EA, Voest EE, van Diest PJ, Borel RI. Ischemia/reperfusion accelerates the outgrowth of hepatic micrometastases in a highly standardized murine model. Hepatology 2005, 42:165-175.
22. van der Bilt JD, Soeters ME, Duyverman AM, Nijkamp MW, Witteveen PO, van Diest PJ, Kranenburg O, Borel RI. Perinecrotic hypoxia contributes to ischemia/reperfusion-accelerated outgrowth of colorectal micrometastases. AmJPathol 2007, 170:1379-1388.
23. Nicoud IB, Jones CM, Pierce JM, Earl TM, Matrisian LM, Chari RS, Gorden DL. Warm hepatic ischemia-reperfusion promotes growth of colorectal carcinoma micrometastases in mouse liver via matrix metalloproteinase-9 induction. Cancer Res 2007, 67:2720-2728. 10.1158/0008-5472.CAN-06-3923, 17363593.
24. Carmeliet P, Jain RK. Angiogenesis in cancer and other diseases. Nature 2000, 407:249-257. 10.1038/35025220, 11001068.
25. Drixler TA, Vogten MJ, Ritchie ED, van Vroonhoven TJ, Gebbink MF, Voest EE, Borel RI. Liver regeneration is an angiogenesis- associated phenomenon. AnnSurg 2002, 236:703-711.
26. Los M, Voest EE, Borel RI. VEGF as a target of therapy in gastrointestinal oncology. DigSurg 2005, 22:282-293.
27. Jensen LJ, Denner L, Schrijvers BF, Tilton RG, Rasch R, Flyvbjerg A. Renal effects of a neutralising RAGE-antibody in long-term streptozotocin-diabetic mice. JEndocrinol 2006, 188:493-501.
28. Schmidt E, Schmidt FW. Enzyme diagnosis of liver diseases. Clin Biochem 1993, 26:241-251. 10.1016/0009-9120(93)90123-N, 8242887.
29. Scheig R. Evaluation of tests used to screen patients with liver disorders. Prim Care 1996, 23:551-560.
30. Giannini EG, Testa R, Savarino V. Liver enzyme alteration: a guide for clinicians. CMAJ 2005, 172:367-379. 10.1503/cmaj.1040752, 545762, 15684121.
31. Peralta C, Hotter G, Closa D, Gelpi E, Bulbena O, Rosello-Catafau J. Protective effect of preconditioning on the injury associated to hepatic ischemia-reperfusion in the rat: role of nitric oxide and adenosine. Hepatology 1997, 25:934-937. 10.1002/hep.510250424, 9096600.
32. Cursio R, Miele C, Filippa N, Van OE, Gugenheim J. Liver HIF-1 alpha induction precedes apoptosis following normothermic ischemia-reperfusion in rats. TransplantProc 2008, 40:2042-2045.
33. Feinman R, Deitch EA, Watkins AC, Abungu B, Colorado I, Kannan KB, Sheth SU, Caputo FJ, Lu Q, Ramanathan M, et al. HIF-1 mediates pathogenic inflammatory responses to intestinal ischemia-reperfusion injury. Am J Physiol Gastrointest Liver Physiol 2010, 299:G833-843. 10.1152/ajpgi.00065.2010, 20689059.
34. Wang YQ, Luk JM, Ikeda K, Man K, Chu AC, Kaneda K, Fan ST. Regulatory role of vHL/HIF-1alpha in hypoxia-induced VEGF production in hepatic stellate cells. BiochemBiophysResCommun 2004, 317:358-362.